Premier Alternatives

VerImmune

Germantown, MD · Founded 2019 · Privately Held (backing)

Developer of a virus-inspired therapeutic delivery platform designed to leverage the natural geometric structure of viruses for targeted payload transport. VerImmune is based in Germantown, MD and was founded in 2019. It was valued at $30 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $10 million across 2 recorded rounds; the latest was a $4.5 million seed round in Aug 2024.

PMV mark · valuation
$30.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$10.0M
Last round
Seed Round
Aug 2024

VerImmune key facts

as of Oct 2026
  • Developer of a virus-inspired therapeutic delivery platform designed to leverage the natural geometric structure of viruses for targeted payload transport.
  • VerImmune is valued at approximately $30.0M as of Oct 2026, set at its later-stage round, Jul 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $10.0M across 2 recorded rounds; the latest was Seed Round ($4.5M) in Aug 2024.
  • Notable investors include US National Science Foundation, Mana Ventures, Gaingels, TEDCO, Ulu Ventures — 12 tracked in total.
  • VerImmune has filed 2 Form Ds with the SEC since 2022, most recently Sep 2024 ($4.5M sold to 6 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$30.0M

Valued at $30.0M at its later-stage round, Jul 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of VerImmune with a free account
  • ·The complete investor list: 12 names
  • ·Watch VerImmune: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

VerImmune funding rounds

2 rounds
Aug 2024Seed Round$4.5MSEC filing▮
Mar 2022Seed Round$1.4MSEC filing▮
Full funding history →

VerImmune valuation

VerImmune was valued at $30 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has VerImmune raised?

VerImmune has raised $10 million in total; 2 of its rounds are on record. The largest on record was a $4.5 million seed round in Aug 2024.

VerImmune has filed 2 Form Ds with the SEC since 2022, most recently in Sep 2024 ($4.5 million sold to 6 investors).

VerImmune investors

12 investors are on record for VerImmune, including US National Science Foundation, Mana Ventures, Gaingels and TEDCO. By type, the record holds 7 venture capital firms. The seed round in Aug 2024 drew 6 investors.

About VerImmune

Developer of a virus-inspired therapeutic delivery platform designed to leverage the natural geometric structure of viruses for targeted payload transport. The company offers a self-assembling Virus-inspired Particle system that carries diverse therapeutic payloads for oncology, autoimmunity, and animal health applications, enabling researchers and developers to pursue targeted treatment strategies across multiple disease areas.

Sector
Healthcare
HQ
Germantown, MD, United States
Founded
2019
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.